These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12530170)

  • 1. [Guidelines for drug therapy of postmenopausal osteoporosis].
    Dimai HP; Pietschmann P; Resch H; Leb G; Klaushofer K
    Wien Med Wochenschr; 2002; 152(23-24):596-612. PubMed ID: 12530170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of vertebral osteoporosis.
    Lippuner K
    Eur Spine J; 2003 Oct; 12 Suppl 2(Suppl 2):S132-41. PubMed ID: 13680313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Large clinical trials for osteoporosis].
    Meunier PJ
    Therapie; 2003; 58(5):415-20. PubMed ID: 14682189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
    Watts NB
    J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to postmenopausal osteoporosis treatment: a case study review.
    Kessenich C
    J Am Acad Nurse Pract; 2003 Dec; 15(12):539-45. PubMed ID: 14983569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
    Reginster JY; Felsenberg D; Pavo I; Stepan J; Payer J; Resch H; Glüer CC; Mühlenbacher D; Quail D; Schmitt H; Nickelsen T
    Osteoporos Int; 2003 Sep; 14(9):741-9. PubMed ID: 12827224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vitamin K2 in the treatment of postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Drug Saf; 2006 Jan; 1(1):87-97. PubMed ID: 18690918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
    Martens MG
    J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM
    Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-resorptive therapy for the prevention of postmenopausal osteoporosis : when should treatment begin?
    Vestergaard P
    Treat Endocrinol; 2005; 4(5):263-77. PubMed ID: 16185096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
    Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of postmenopausal osteoporosis.
    Delmas PD
    Lancet; 2002 Jun; 359(9322):2018-26. PubMed ID: 12076571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.